CRISPR-based peptide library display and programmable microarray self-assembly for rapid quantitative protein binding assays
- PMID: 34390675
- DOI: 10.1016/j.molcel.2021.07.027
CRISPR-based peptide library display and programmable microarray self-assembly for rapid quantitative protein binding assays
Abstract
CRISPR-inspired systems have been extensively developed for applications in genome editing and nucleic acid detection. Here, we introduce a CRISPR-based peptide display technology to facilitate customized, high-throughput in vitro protein interaction studies. We show that bespoke peptide libraries fused to catalytically inactive Cas9 (dCas9) and barcoded with unique single guide RNA (sgRNA) molecules self-assemble from a single mixed pool to programmable positions on a DNA microarray surface for rapid, multiplexed binding assays. We develop dCas9-displayed saturation mutagenesis libraries to characterize antibody-epitope binding for a commercial anti-FLAG monoclonal antibody and human serum antibodies. We also show that our platform can be used for viral epitope mapping and exhibits promise as a multiplexed diagnostics tool. Our CRISPR-based peptide display platform and the principles of complex library self-assembly using dCas9 could be adapted for rapid interrogation of varied customized protein libraries or biological materials assembly using DNA scaffolding.
Keywords: CRISPR; Cas9; FLAG; SARS-CoV-2; antibody binding; influenza A; protein display; protein microarray; protein-protein interactions; self-assembly.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests K.W.B. and S.J.E. have filed a provisional patent application with the US Patent and Trademark Office (US Patent Application no. 63/220,399) related to this work. S.J.E. is a founder of TScan Therapeutics, Maze Therapeutics, ImmuneID, and Mirimus. S.J.E. is a scientific advisory board member for Homology Medicines, TScan Therapeutics, Maze Therapeutics, X-Chem, and Molecular Cell and is an advisor for MPM Capital. K.W.B. is a consultant for BigHat Biosciences.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
